Literature DB >> 33859300

A novel tissue specific alternative splicing variant mitigates phenotypes in Ets2 frame-shift mutant models.

Yuki Kishimoto1, Iori Nishiura1, Wataru Hirata1, Shunsuke Yuri1, Nami Yamamoto1, Masahito Ikawa2, Ayako Isotani3.   

Abstract

E26 avian leukemia oncogene 2, 3' domain (Ets2) has been implicated in various biological processes. An Ets2 mutant model (Ets2db1/db1), which lacks the DNA-binding domain, was previously reported to exhibit embryonic lethality caused by a trophoblast abnormality. This phenotype could be rescued by tetraploid complementation, resulting in pups with wavy hair and curly whiskers. Here, we generated new Ets2 mutant models with a frame-shift mutation in exon 8 using the CRISPR/Cas9 method. Homozygous mutants could not be obtained by natural mating as embryonic development stopped before E8.5, as previously reported. When we rescued them by tetraploid complementation, these mice did not exhibit wavy hair or curly whisker phenotypes. Our newly generated mice exhibited exon 8 skipping, which led to in-frame mutant mRNA expression in the skin and thymus but not in E7.5 Ets2em1/em1 embryos. This exon 8-skipped Ets2 mRNA was translated into protein, suggesting that this Ets2 mutant protein complemented the Ets2 function in the skin. Our data implies that novel splicing variants incidentally generated after genome editing may complicate the phenotypic analysis but may also give insight into the new mechanisms related to biological gene functions.

Entities:  

Year:  2021        PMID: 33859300     DOI: 10.1038/s41598-021-87751-5

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  23 in total

Review 1.  The ETS-domain transcription factor family.

Authors:  A D Sharrocks
Journal:  Nat Rev Mol Cell Biol       Date:  2001-11       Impact factor: 94.444

2.  Activated Ets2 is required for persistent inflammatory responses in the motheaten viable model.

Authors:  Guo Wei; Jianping Guo; Andrea I Doseff; Donna F Kusewitt; Albert K Man; Robert G Oshima; Michael C Ostrowski
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

3.  The ETS-domain: a new DNA-binding motif that recognizes a purine-rich core DNA sequence.

Authors:  F D Karim; L D Urness; C S Thummel; M J Klemsz; S R McKercher; A Celada; C Van Beveren; R A Maki; C V Gunther; J A Nye
Journal:  Genes Dev       Date:  1990-09       Impact factor: 11.361

4.  Complementation of placental defects and embryonic lethality by trophoblast-specific lentiviral gene transfer.

Authors:  Yuka Okada; Yuko Ueshin; Ayako Isotani; Tomoko Saito-Fujita; Hisako Nakashima; Kazushi Kimura; Akira Mizoguchi; Masatsugu Oh-Hora; Yoshiko Mori; Masato Ogata; Robert G Oshima; Masaru Okabe; Masahito Ikawa
Journal:  Nat Biotechnol       Date:  2007-01-14       Impact factor: 54.908

5.  Ets1 and Ets2 are required for endothelial cell survival during embryonic angiogenesis.

Authors:  Guo Wei; Ruchika Srinivasan; Carmen Z Cantemir-Stone; Sudarshana M Sharma; Ramasamy Santhanam; Michael Weinstein; Natarajan Muthusamy; Albert K Man; Robert G Oshima; Gustavo Leone; Michael C Ostrowski
Journal:  Blood       Date:  2009-05-01       Impact factor: 22.113

6.  Transcription factor ets-2 plays an important role in the pathogenesis of pulmonary fibrosis.

Authors:  Christopher P Baran; Sara N Fischer; Gerard J Nuovo; Mohamed N Kabbout; Charles L Hitchcock; Benjamin D Bringardner; Sara McMaken; Christie A Newland; Carmen Z Cantemir-Stone; Gary S Phillips; Michael C Ostrowski; Clay B Marsh
Journal:  Am J Respir Cell Mol Biol       Date:  2011-05-11       Impact factor: 6.914

7.  Defective trophoblast function in mice with a targeted mutation of Ets2.

Authors:  H Yamamoto; M L Flannery; S Kupriyanov; J Pearce; S R McKercher; G W Henkel; R A Maki; Z Werb; R G Oshima
Journal:  Genes Dev       Date:  1998-05-01       Impact factor: 11.361

8.  An ERK2 docking site in the Pointed domain distinguishes a subset of ETS transcription factors.

Authors:  Jeffrey J Seidel; Barbara J Graves
Journal:  Genes Dev       Date:  2002-01-01       Impact factor: 11.361

9.  Multiplex genome engineering using CRISPR/Cas systems.

Authors:  Le Cong; F Ann Ran; David Cox; Shuailiang Lin; Robert Barretto; Naomi Habib; Patrick D Hsu; Xuebing Wu; Wenyan Jiang; Luciano A Marraffini; Feng Zhang
Journal:  Science       Date:  2013-01-03       Impact factor: 47.728

10.  Ets2-dependent stromal regulation of mouse mammary tumors.

Authors:  Albert K Man; Lawrence J T Young; John A Tynan; Jacqueline Lesperance; Mikala Egeblad; Zena Werb; Craig A Hauser; William J Muller; Robert D Cardiff; Robert G Oshima
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

View more
  1 in total

1.  Generation of the Y-chromosome linked red fluorescent protein transgenic mouse model and sexing at the preimplantation stage.

Authors:  Wataru Hirata; Taiki Tomoda; Shunsuke Yuri; Ayako Isotani
Journal:  Exp Anim       Date:  2021-09-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.